▶ 調査レポート

世界のシタグリプチン錠剤市場(~2028年):25mg、50mg、100mg

• 英文タイトル:Global Sitagliptin Tablet Market Insights, Forecast to 2028

Global Sitagliptin Tablet Market Insights, Forecast to 2028「世界のシタグリプチン錠剤市場(~2028年):25mg、50mg、100mg」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-19478
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、79ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医薬品&医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、シタグリプチン錠剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
シタグリプチン錠剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
シタグリプチン錠剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
シタグリプチン錠剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのシタグリプチン錠剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のシタグリプチン錠剤の売上および2028年までの予測に焦点を当てています。

シタグリプチン錠剤のグローバル主要企業には、Merck、Pharmaffiliatesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

シタグリプチン錠剤市場は、タイプとアプリケーションによって区分されます。世界のシタグリプチン錠剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
25mg、50mg、100mg

【アプリケーション別セグメント】
糖尿病、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- シタグリプチン錠剤製品概要
- タイプ別市場(25mg、50mg、100mg)
- アプリケーション別市場(糖尿病、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のシタグリプチン錠剤販売量予測2017-2028
- 世界のシタグリプチン錠剤売上予測2017-2028
- シタグリプチン錠剤の地域別販売量
- シタグリプチン錠剤の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別シタグリプチン錠剤販売量
- 主要メーカー別シタグリプチン錠剤売上
- 主要メーカー別シタグリプチン錠剤価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(25mg、50mg、100mg)
- シタグリプチン錠剤のタイプ別販売量
- シタグリプチン錠剤のタイプ別売上
- シタグリプチン錠剤のタイプ別価格
・アプリケーション別市場規模(糖尿病、その他)
- シタグリプチン錠剤のアプリケーション別販売量
- シタグリプチン錠剤のアプリケーション別売上
- シタグリプチン錠剤のアプリケーション別価格
・北米市場
- 北米のシタグリプチン錠剤市場規模(タイプ別、アプリケーション別)
- 主要国別のシタグリプチン錠剤市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのシタグリプチン錠剤市場規模(タイプ別、アプリケーション別)
- 主要国別のシタグリプチン錠剤市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のシタグリプチン錠剤市場規模(タイプ別、アプリケーション別)
- 主要国別のシタグリプチン錠剤市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のシタグリプチン錠剤市場規模(タイプ別、アプリケーション別)
- 主要国別のシタグリプチン錠剤市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのシタグリプチン錠剤市場規模(タイプ別、アプリケーション別)
- 主要国別のシタグリプチン錠剤市場規模(トルコ、サウジアラビア)
・企業情報
Merck、Pharmaffiliates
・産業チェーン及び販売チャネル分析
- シタグリプチン錠剤の産業チェーン分析
- シタグリプチン錠剤の原材料
- シタグリプチン錠剤の生産プロセス
- シタグリプチン錠剤の販売及びマーケティング
- シタグリプチン錠剤の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- シタグリプチン錠剤の産業動向
- シタグリプチン錠剤のマーケットドライバー
- シタグリプチン錠剤の課題
- シタグリプチン錠剤の阻害要因
・主な調査結果

Sitagliptin is used along with diet and exercise and sometimes with other medications to lower blood sugar levels in adults with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally).
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sitagliptin Tablet is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sitagliptin Tablet is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sitagliptin Tablet is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Sitagliptin Tablet include Merck and Pharmaffiliates etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sitagliptin Tablet manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sitagliptin Tablet market. Further, it explains the major drivers and regional dynamics of the global Sitagliptin Tablet market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Merck
Pharmaffiliates
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Sitagliptin Tablet Segment by Type
25mg
50mg
100mg
Sitagliptin Tablet Segment by Application
Diabetes
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sitagliptin Tablet market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sitagliptin Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sitagliptin Tablet, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Sitagliptin Tablet, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sitagliptin Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Sitagliptin Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Sitagliptin Tablet sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck and Pharmaffiliates etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Sitagliptin Tablet in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Sitagliptin Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sitagliptin Tablet sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Sitagliptin Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Sitagliptin Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 25mg
1.2.3 50mg
1.2.4 100mg
1.3 Market by Application
1.3.1 Global Sitagliptin Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diabetes
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sitagliptin Tablet Sales Estimates and Forecasts 2017-2028
2.2 Global Sitagliptin Tablet Revenue Estimates and Forecasts 2017-2028
2.3 Global Sitagliptin Tablet Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Sitagliptin Tablet Sales by Region
2.4.1 Global Sitagliptin Tablet Sales by Region (2017-2022)
2.4.2 Global Sales Sitagliptin Tablet by Region (2023-2028)
2.5 Global Sitagliptin Tablet Revenue by Region
2.5.1 Global Sitagliptin Tablet Revenue by Region (2017-2022)
2.5.2 Global Sitagliptin Tablet Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Sitagliptin Tablet Sales by Manufacturers
3.1.1 Global Top Sitagliptin Tablet Manufacturers by Sales (2017-2022)
3.1.2 Global Sitagliptin Tablet Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sitagliptin Tablet in 2021
3.2 Global Sitagliptin Tablet Revenue by Manufacturers
3.2.1 Global Sitagliptin Tablet Revenue by Manufacturers (2017-2022)
3.2.2 Global Sitagliptin Tablet Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Sitagliptin Tablet Revenue in 2021
3.3 Global Sitagliptin Tablet Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sitagliptin Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sitagliptin Tablet Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sitagliptin Tablet Sales by Type
4.1.1 Global Sitagliptin Tablet Historical Sales by Type (2017-2022)
4.1.2 Global Sitagliptin Tablet Forecasted Sales by Type (2023-2028)
4.1.3 Global Sitagliptin Tablet Sales Market Share by Type (2017-2028)
4.2 Global Sitagliptin Tablet Revenue by Type
4.2.1 Global Sitagliptin Tablet Historical Revenue by Type (2017-2022)
4.2.2 Global Sitagliptin Tablet Forecasted Revenue by Type (2023-2028)
4.2.3 Global Sitagliptin Tablet Revenue Market Share by Type (2017-2028)
4.3 Global Sitagliptin Tablet Price by Type
4.3.1 Global Sitagliptin Tablet Price by Type (2017-2022)
4.3.2 Global Sitagliptin Tablet Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Sitagliptin Tablet Sales by Application
5.1.1 Global Sitagliptin Tablet Historical Sales by Application (2017-2022)
5.1.2 Global Sitagliptin Tablet Forecasted Sales by Application (2023-2028)
5.1.3 Global Sitagliptin Tablet Sales Market Share by Application (2017-2028)
5.2 Global Sitagliptin Tablet Revenue by Application
5.2.1 Global Sitagliptin Tablet Historical Revenue by Application (2017-2022)
5.2.2 Global Sitagliptin Tablet Forecasted Revenue by Application (2023-2028)
5.2.3 Global Sitagliptin Tablet Revenue Market Share by Application (2017-2028)
5.3 Global Sitagliptin Tablet Price by Application
5.3.1 Global Sitagliptin Tablet Price by Application (2017-2022)
5.3.2 Global Sitagliptin Tablet Price Forecast by Application (2023-2028)
6 North America
6.1 North America Sitagliptin Tablet Market Size by Type
6.1.1 North America Sitagliptin Tablet Sales by Type (2017-2028)
6.1.2 North America Sitagliptin Tablet Revenue by Type (2017-2028)
6.2 North America Sitagliptin Tablet Market Size by Application
6.2.1 North America Sitagliptin Tablet Sales by Application (2017-2028)
6.2.2 North America Sitagliptin Tablet Revenue by Application (2017-2028)
6.3 North America Sitagliptin Tablet Market Size by Country
6.3.1 North America Sitagliptin Tablet Sales by Country (2017-2028)
6.3.2 North America Sitagliptin Tablet Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Sitagliptin Tablet Market Size by Type
7.1.1 Europe Sitagliptin Tablet Sales by Type (2017-2028)
7.1.2 Europe Sitagliptin Tablet Revenue by Type (2017-2028)
7.2 Europe Sitagliptin Tablet Market Size by Application
7.2.1 Europe Sitagliptin Tablet Sales by Application (2017-2028)
7.2.2 Europe Sitagliptin Tablet Revenue by Application (2017-2028)
7.3 Europe Sitagliptin Tablet Market Size by Country
7.3.1 Europe Sitagliptin Tablet Sales by Country (2017-2028)
7.3.2 Europe Sitagliptin Tablet Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sitagliptin Tablet Market Size by Type
8.1.1 Asia Pacific Sitagliptin Tablet Sales by Type (2017-2028)
8.1.2 Asia Pacific Sitagliptin Tablet Revenue by Type (2017-2028)
8.2 Asia Pacific Sitagliptin Tablet Market Size by Application
8.2.1 Asia Pacific Sitagliptin Tablet Sales by Application (2017-2028)
8.2.2 Asia Pacific Sitagliptin Tablet Revenue by Application (2017-2028)
8.3 Asia Pacific Sitagliptin Tablet Market Size by Region
8.3.1 Asia Pacific Sitagliptin Tablet Sales by Region (2017-2028)
8.3.2 Asia Pacific Sitagliptin Tablet Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Sitagliptin Tablet Market Size by Type
9.1.1 Latin America Sitagliptin Tablet Sales by Type (2017-2028)
9.1.2 Latin America Sitagliptin Tablet Revenue by Type (2017-2028)
9.2 Latin America Sitagliptin Tablet Market Size by Application
9.2.1 Latin America Sitagliptin Tablet Sales by Application (2017-2028)
9.2.2 Latin America Sitagliptin Tablet Revenue by Application (2017-2028)
9.3 Latin America Sitagliptin Tablet Market Size by Country
9.3.1 Latin America Sitagliptin Tablet Sales by Country (2017-2028)
9.3.2 Latin America Sitagliptin Tablet Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Sitagliptin Tablet Market Size by Type
10.1.1 Middle East and Africa Sitagliptin Tablet Sales by Type (2017-2028)
10.1.2 Middle East and Africa Sitagliptin Tablet Revenue by Type (2017-2028)
10.2 Middle East and Africa Sitagliptin Tablet Market Size by Application
10.2.1 Middle East and Africa Sitagliptin Tablet Sales by Application (2017-2028)
10.2.2 Middle East and Africa Sitagliptin Tablet Revenue by Application (2017-2028)
10.3 Middle East and Africa Sitagliptin Tablet Market Size by Country
10.3.1 Middle East and Africa Sitagliptin Tablet Sales by Country (2017-2028)
10.3.2 Middle East and Africa Sitagliptin Tablet Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Sitagliptin Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Sitagliptin Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Pharmaffiliates
11.2.1 Pharmaffiliates Corporation Information
11.2.2 Pharmaffiliates Overview
11.2.3 Pharmaffiliates Sitagliptin Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pharmaffiliates Sitagliptin Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pharmaffiliates Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sitagliptin Tablet Industry Chain Analysis
12.2 Sitagliptin Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sitagliptin Tablet Production Mode & Process
12.4 Sitagliptin Tablet Sales and Marketing
12.4.1 Sitagliptin Tablet Sales Channels
12.4.2 Sitagliptin Tablet Distributors
12.5 Sitagliptin Tablet Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sitagliptin Tablet Industry Trends
13.2 Sitagliptin Tablet Market Drivers
13.3 Sitagliptin Tablet Market Challenges
13.4 Sitagliptin Tablet Market Restraints
14 Key Findings in The Global Sitagliptin Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer